1-2 of 2
Marco Vignetti
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CDKN2A/B Alterations Impair Prognosis in Adult BCR-ABL1–Positive Acute Lymphoblastic Leukemia Patients

Ilaria Iacobucci, Anna Ferrari, Annalisa Lonetti, Cristina Papayannidis, Francesca Paoloni, Stefania Trino, Clelia Tiziana Storlazzi, Emanuela Ottaviani, Federica Cattina, Luciana Impera, Maria Chiara Abbenante, Marco Vignetti, Antonella Vitale, Leonardo Potenza, Stefania Paolini, Simona Soverini, Fabrizio Pane, Mario Luppi, Robin Foà, Michele Baccarani, Giovanni Martinelli
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (23): 7413–7423.
https://doi.org/10.1158/1078-0432.CCR-11-1227
Published: 30 November 2011
View articletitled, CDKN2A/B Alterations Impair Prognosis in Adult BCR-ABL1–Positive Acute Lymphoblastic Leukemia Patients
Open the PDF for CDKN2A/B Alterations Impair Prognosis in Adult BCR-ABL1–Positive Acute Lymphoblastic Leukemia Patients in another window
Includes: Supplementary data
Journal Articles

Valproic Acid at Therapeutic Plasma Levels May Increase 5-Azacytidine Efficacy in Higher Risk Myelodysplastic Syndromes

Maria Teresa Voso, Valeria Santini, Carlo Finelli, Pellegrino Musto, Enrico Pogliani, Emanuele Angelucci, Giuseppe Fioritoni, Giuliana Alimena, Luca Maurillo, Agostino Cortelezzi, Francesco Buccisano, Marco Gobbi, Lorenza Borin, Anna Di Tucci, Gina Zini, Maria Concetta Petti, Giovanni Martinelli, Emiliano Fabiani, Paola Fazi, Marco Vignetti, Alfonso Piciocchi, Vincenzo Liso, Sergio Amadori, Giuseppe Leone
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (15): 5002–5007.
https://doi.org/10.1158/1078-0432.CCR-09-0494
Published: 29 July 2009
View articletitled, Valproic Acid at Therapeutic Plasma Levels May Increase 5-Azacytidine Efficacy in Higher Risk Myelodysplastic Syndromes
Open the PDF for Valproic Acid at Therapeutic Plasma Levels May Increase 5-Azacytidine Efficacy in Higher Risk Myelodysplastic Syndromes in another window
Includes: Supplementary data